Cara Yakhte Tajhiz Azma Company, by employing a research group, is active in the field of ‘Development and Characterization of Engineered T-lymphocytes Carrying a CD19-Specific Nanobody for Use in Cancer Immunotherapy’ and the production of a pediatric leukemia vaccine.